Method of preventing allograft rejection

Details Method of preventing allograft rejection Method of preventing allograft rejection

A - Human Necessities

61

K

A61K 31/41 (2006.01) A61K 31/122 (2006.01) A61K 31/335 (2006.01) A61K 31/34 (2006.01) A61K 31/35 (2006.01) A61K 31/353 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/422 (2006.01) A61K 31/44 (2006.01) A61K 31/55 (2006.01)

Patent

CA 2269046

Disclosed is a medicine for suppressing the rejection of allogeneic transplants in a mammal, including a human, which comprises a compound of the formula: (see formula I) (wherein n is 1, 2 or 3; A is O, S, CH2, NH or N-alkyl; B is CHR3 and R3 is H, aryl-aryl or aryl-aryl-alkyl; R1 may be one of a variety of groups such as carboxyl-(C3-C7)cycloalkyl; and R2 is H or a substituent) or the pharmaceutically acceptable salt thereof.

Affiliated with

Also associated with

Rating

Method of preventing allograft rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preventing allograft rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing allograft rejection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1577555